
1. j infect dis. 2013 mar 1;207(5):842-7. doi: 10.1093/infdis/jis747. epub 2012 dec 
5.

plasmodium falciparum drug resistance phenotype assessed patient
antimalarial drug levels association pfmdr1 polymorphisms.

malmberg m(1), ferreira pe, tarning j, ursing j, ngasala b, björkman a,
mårtensson a, gil jp.

author information: 
(1)malaria research, infectious disease unit, department medicine solna,
stockholm, sweden. maja.malmberg@ki.se

background: multidrug-resistant plasmodium falciparum major threat global
malaria control. parasites develop resistance gradually acquiring genetic
polymorphisms decrease drug susceptibility. aim study to
investigate extent parasites different genetic characteristics 
are able withstand individual drug blood concentrations.
methods: analyzed 2 clinical trials assessed efficacy and
effectiveness artemether-lumefantrine. proof concept, used measured
day 7 lumefantrine concentrations estimate concentrations which
reinfections multiplied. p. falciparum multidrug resistance gene 1 (pfmdr1)
genotypes parasites correlated drug susceptibility.
results: reinfecting parasites pfmdr1 n86/184f/d1246 haplotype able
to withstand lumefantrine blood concentrations 15-fold higher the
86y/y184/1246y haplotype.
conclusions: estimating drug concentrations, able quantify the
contribution pfmdr1 single-nucleotide polymorphisms reduced lumefantrine
susceptibility. method applied long-half-life antimalarial
drugs, enables early detection p. falciparum reduced drug susceptibility 
in vivo, represents novel way unveiling molecular markers of
antimalarial drug resistance.

doi: 10.1093/infdis/jis747 
pmcid: pmc3563306
pmid: 23225895  [indexed medline]

